Physician profile
Jana Ivanidze
NPI 1144500992
$9,038.21
in general payments reported to CMS, 2019-2025
9 companies · $3,259 in 2025
The $3,259 reported for 2025 was more than what 93% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2022: $55.92 · 2023: $4,282 · 2024: $1,194 · 2025: $3,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,063 · Travel and Lodging: $3,020 · Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,062.50 |
| Travel and Lodging | $3,019.64 |
| Food and Beverage | $1,652.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,161.42 | 2022-2023 | Lutathera |
| Siemens Medical Solutions USA, INC. | $2,633.06 | 2019-2025 | Biograph Trinion Ep Ct64, Biograph Mct X-4r, Symbia Pro.Specta X3 |
| Ge Healthcare | $1,154.01 | 2025 | |
| Telix Pharmaceuticals | $814.01 | 2024-2025 | Illuccix |
| Life Molecular Imaging Ltd | $84.92 | 2025 | Neuraceq |
| Curium US LLC | $74.71 | 2024-2025 | Detectnet |
| Gt Medical Technologies, INC | $55.44 | 2024 | Gammatile |
| Bayer Healthcare Pharmaceuticals INC. | $31.15 | 2025 | |
| Progenics Pharmaceuticals, INC. | $29.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jana Ivanidze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.